Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)
Others
Ratios

Bioadaptives (BDPT) Gross Profit (2019 - 2025)

Historic Gross Profit for Bioadaptives (BDPT) over the last 7 years, with Q3 2025 value amounting to $3851.0.

  • Bioadaptives' Gross Profit changed N/A to $3851.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4914.0, marking a year-over-year decrease of 2697.28%. This contributed to the annual value of $4030.0 for FY2024, which is 6275.07% down from last year.
  • According to the latest figures from Q3 2025, Bioadaptives' Gross Profit is $3851.0.
  • Bioadaptives' Gross Profit's 5-year high stood at $4650.0 during Q3 2023, with a 5-year trough of $429.0 in Q2 2024.
  • Its 5-year average for Gross Profit is $2312.1, with a median of $2076.5 in 2022.
  • In the last 5 years, Bioadaptives' Gross Profit soared by 218027.21% in 2021 and then crashed by 7120.81% in 2024.
  • Quarter analysis of 5 years shows Bioadaptives' Gross Profit stood at $1142.0 in 2021, then dropped by 9.81% to $1030.0 in 2022, then surged by 162.04% to $2699.0 in 2023, then tumbled by 84.11% to $429.0 in 2024, then soared by 797.67% to $3851.0 in 2025.
  • Its Gross Profit stands at $3851.0 for Q3 2025, versus $1063.0 for Q2 2025 and $429.0 for Q2 2024.